Michael Vigilante
Director/Board Member at Corium LLC
Profile
Mr. Michael Vigilante is an Analyst at Gurnet Point Capital.
Prior to joining Gurnet Point Capital in 2014, Mr. Vigilante was an analyst in the investment banking group of MTS Health Partners.
Mr. Vigilante graduated from University of Pennsylvania, and holds a BS from the Wharton School of Business and a BA in Biology.
Michael Vigilante active positions
| Companies | Position | Start |
|---|---|---|
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analyst | 2013-12-31 |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Director/Board Member | - |
Former positions of Michael Vigilante
| Companies | Position | End |
|---|---|---|
| MTS Health Partners GP LLC | Corporate Officer/Principal | 2013-12-30 |
Training of Michael Vigilante
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| MTS Health Partners GP LLC | |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Health Technology |
- Stock Market
- Insiders
- Michael Vigilante
